The top analyst upgrades, downgrades and initiations seen on Tuesday include Mobileye, Occidental Petroleum, Oracle, Walt Disney, Wal-Mart.
Wednesday’s top analyst upgrades, downgrades and initiations include Abbott Labs, General Dynamics, Nexstar Media, Owens Corning, Palo Alto Networks and Salesforce.com.
With inflation, higher interest rates and a host of potential volatility events around the corner, it makes sense now to play it safe. The place to look now is for growth companies…
These five stocks pay solid distributions, are not trading at all-time highs and are rated Buy at Merrill Lynch. They make good sense should a big sell-off hit the market.
The pricier the market gets, the more it makes sense to stay with industry leaders, especially those that have paid and raised their dividends consistently.
Bank of America, Chesapeake Energy and General Electric all saw double-digit percentage drops in their short interest in the waning days of 2016.
For more conservative investors looking for growth and income, these stocks make good sense for 2017 and beyond.
The pending holiday didn’t slow insiders from buying shares, and we continued to see some strong trading during the week.
Judging by moves among the most shorted stocks traded on the New York Stock Exchange, short sellers took a cautious approach late last month,
These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all trading well below their 52-week highs and should be attracting substantial institutional…
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
Last week, following the election, the insiders were back with a vengeance, and the buyers were out in full force.
With earnings for the third quarter wrapping up, executives and 10% owners that are insiders are once again free to trade shares, and volume is starting to pick up again.
The relentless populist rhetoric has lowered the prices on some of the top pharmaceutical companies, and long-term growth and income investors have a chance to buy some great stocks on sale.
These are 14 companies in the S&P 500 Index that have at least a 25 year history of dividend hikes and that seem likely to keep increasing their dividends in the coming…
